Dementia Care Costs: Formal and Informal Burden to 2030 | Policy & Market Intelligence

Description

List of Tables

Dementia is Japan's most expensive condition once informal care is counted, and the counting matters. Formal costs, medical services and long-term care delivered through insurance, are visible in budget documents. Informal costs, the unpaid labor of family caregivers and the productivity it displaces, are larger by most methodological conventions and largely invisible to the systems that plan around them. As the dementia population grows toward the end of the decade, the question of who bears which share of this burden is moving from academic modeling into insurance product design, reinsurance pricing, and long-term-care system planning.

The analytical problem is that the cost literature is fragmented across disciplines. Per-patient cost estimates differ by setting, severity stage, and accounting convention. The informal-care literature uses valuation methods that produce widely divergent totals. Disease-modifying therapy adds a new, poorly characterized cost layer: drug acquisition is only part of it, with eligibility testing, infusion delivery, and monitoring all drawing on the same budgets. Payers, insurers, and reinsurers each see a different slice of the exposure, and no single framework reconciles them.

This report builds that reconciliation. It synthesizes the formal-cost literature across medical and long-term-care channels, maps informal-care valuation methodologies and their implications, and projects the cost structure forward under demographic scenarios to 2030. It profiles the exposure holders: insurers with dementia-linked products, Sompo Holdings, Nippon Life, Dai-ichi Life, MS&AD, Tokio Marine, Meiji Yasuda, and Aflac's Japanese channel; reinsurers including Swiss Re and Munich Re active in longevity and morbidity risk; and the operator cost base represented by Nichii Gakkan and Benesse Style Care. The treatment-cost chapters examine how Leqembi and Kisunla, through Eisai and Lilly, enter payer budgets. International sections benchmark Japan against US, EU5, and Chinese dementia-cost structures.

The report is written for insurers and reinsurers modeling morbidity and longevity exposure, LTCI planners and policy teams, care operators building cost benchmarks, pharma market-access teams defending therapy budgets, and investors assessing dementia-linked insurance and care businesses. Methodologies are presented transparently so readers can stress every estimate against its assumptions.

Scope and Coverage

The report covers formal and informal dementia-care cost structures in Japan with projections to 2030, spanning medical, long-term-care, and household channels, plus the insurance and reinsurance exposure layer, with international benchmarks from the US, EU5, and China. It addresses cost architecture and payer exposure rather than clinical outcomes.

Report Highlights

Formal-cost synthesis across medical and LTCI channels
Informal-care valuation methodologies and their divergence explained
Dementia-therapy cost layer: eligibility, delivery, and monitoring components
Insurer and reinsurer exposure mapping with product structures
Operator cost-base benchmarks from major care providers
Demographic-scenario projection framework to 2030

Product Code: JPH-009

Table of Content

1. Executive Summary

2. Dementia Care Costs: Policy and Institutional Framework

3. Reimbursement, Pricing, and Funding Flows

4. Provider and Operator Landscape: Structure and Economics

5. Workforce and Capacity Analysis

6. Technology and Vendor Ecosystem

7. International Comparison: US, EU5, and China

8. Implications for Entrants and Investors

9. Appendix: Methodology and Sources

Companies Mentioned

Sompo Holdings (JP) - insurer-operator group running Sompo Care dementia facilities
Nippon Life (JP) - dementia insurance and the Nichii care-operator acquisition
Dai-ichi Life (JP) - dementia-recognition insurance products
MS&AD Insurance Group (JP) - long-term-care insurance exposure
Tokio Marine (JP) - LTC-related insurance lines
Meiji Yasuda Life (JP) - dementia-coverage riders and annuities
Swiss Re (CH) - reinsurance capacity for Japanese LTC and morbidity risk
Munich Re (DE) - reinsurance and longevity-risk transfer
Eisai (JP) - Leqembi treatment costs affecting care-budget modeling
Eli Lilly (US) - Kisunla cost impact on payer exposure
Nichii Gakkan (JP) - largest home-care operator cost base
Benesse Style Care (JP) - residential dementia-care cost benchmarks
Aflac (US) - supplemental insurance sold through the Japanese channel

Product Code: JPH-009

List of Tables

Table 1. Dementia cost-of-illness framework: formal, informal, and intangible components
Table 2. Cost-category taxonomy: medical, long-term-care, household, and societal perspectives
Table 3. Methodological conventions in dementia cost estimation
Table 4. Milestones in Japanese dementia cost research and policy response by year
Table 5. Dementia population structure by severity stage and care setting
Table 6. Comorbidity structure affecting dementia cost profiles
Table 7. Care-setting distribution: home, day service, residential, and hospital
Table 8. Caregiver population structure: family relationships and employment status
Table 9. Regional variation frameworks for dementia care costs
Table 10. Medical-cost channels: hospital, outpatient, and pharmaceutical components
Table 11. LTCI service costs: home care, day services, and residential care structures
Table 12. Informal-care valuation methods: replacement-cost and opportunity-cost approaches
Table 13. Caregiver time-use and employment-impact frameworks
Table 14. Out-of-pocket cost components borne by households
Table 15. Disease-modifying therapy cost layer: drug, testing, infusion, and monitoring components
Table 16. Leqembi and Kisunla treatment-pathway cost structure under NHI
Table 17. Symptomatic-treatment and behavioral-symptom medication cost channels
Table 18. Hospitalization and institutionalization cost escalation frameworks
Table 19. End-of-life care cost patterns in dementia
Table 20. Per-patient cost literature: study inventory and methodology comparison
Table 21. National-level cost synthesis frameworks for Japan
Table 22. Projection methodology: demographic scenarios and cost-per-case assumptions
Table 23. Sensitivity-structure of dementia cost projections to 2030
Table 24. International comparison: US, EU5, and China cost structures
Table 25. NHI medical-insurance exposure to dementia-related costs
Table 26. LTCI system exposure: benefit structure and fiscal mechanics
Table 27. Private dementia-insurance products: Sompo Holdings and Sompo Care structure
Table 28. Nippon Life: dementia insurance and the Nichii operator integration
Table 29. Dai-ichi Life, MS&AD, and Tokio Marine: dementia-linked product lines
Table 30. Meiji Yasuda riders and annuities with dementia coverage
Table 31. Aflac supplemental-insurance channel in Japan
Table 32. Swiss Re and Munich Re: reinsurance structures for LTC and morbidity risk
Table 33. Reinsurance treaty structures relevant to Japanese longevity risk
Table 34. Underwriting and claims frameworks for dementia-recognition products
Table 35. Operator cost base: Nichii Gakkan home-care economics
Table 36. Operator cost base: Benesse Style Care residential economics
Table 37. Staffing-cost structure across dementia care settings
Table 38. Facility-investment and capacity-cost frameworks
Table 39. Eisai and Lilly treatment costs in payer-budget modeling
Table 40. Pharma market-access perspectives on dementia therapy budgeting
Table 41. Payer negotiation structures for high-cost dementia therapies
Table 42. Public-finance implications: central and municipal budget exposure
Table 43. Household-finance implications: savings drawdown and asset-management needs
Table 44. Unmet needs: data gaps in informal-care measurement
Table 45. Insurance-product design opportunities linked to dementia trajectories
Table 46. LTCI planning applications of reconciled cost frameworks
Table 47. Reinsurance and risk-transfer opportunities in Japanese dementia exposure
Table 48. Scenario agenda: policy events that change the cost structure
Table 49. Report methodology: literature synthesis, model structure, and assumptions log
Table 50. Glossary of cost, insurance, and care-system terms

List of Figures

Figure 1. Dementia cost-of-illness framework diagram
Figure 2. Cost-category taxonomy map
Figure 3. Methodological-convention comparison schematic
Figure 4. Timeline of dementia cost research and policy response in Japan
Figure 5. Severity-stage and care-setting population structure
Figure 6. Comorbidity web affecting cost profiles
Figure 7. Care-setting distribution map framework
Figure 8. Caregiver population structure diagram
Figure 9. Regional cost-variation framework map
Figure 10. Medical-cost channel architecture
Figure 11. LTCI service-cost structure by care type
Figure 12. Informal-care valuation method comparison
Figure 13. Caregiver time-use and employment-impact schematic
Figure 14. Household out-of-pocket cost component map
Figure 15. DMT cost-layer anatomy: testing, drug, infusion, monitoring
Figure 16. Leqembi and Kisunla pathway cost structure under NHI
Figure 17. Symptomatic-treatment cost channel map
Figure 18. Hospitalization and institutionalization escalation pathway
Figure 19. End-of-life cost pattern framework
Figure 20. Per-patient cost literature map by methodology
Figure 21. National cost-synthesis framework diagram
Figure 22. Projection model architecture to 2030
Figure 23. Sensitivity-structure schematic for projections
Figure 24. International cost-structure comparison map
Figure 25. NHI exposure diagram for dementia-related costs
Figure 26. LTCI benefit and fiscal mechanics flow
Figure 27. Sompo Holdings dementia product and operator structure
Figure 28. Nippon Life insurance-operator integration map
Figure 29. Dai-ichi Life, MS&AD, and Tokio Marine product map
Figure 30. Meiji Yasuda dementia-coverage product structure
Figure 31. Aflac channel structure in Japan
Figure 32. Swiss Re and Munich Re reinsurance positioning
Figure 33. Reinsurance treaty structure diagram
Figure 34. Underwriting and claims framework for dementia products
Figure 35. Nichii Gakkan home-care cost structure
Figure 36. Benesse Style Care residential cost structure
Figure 37. Staffing-cost architecture across care settings
Figure 38. Facility-investment and capacity-cost framework
Figure 39. Eisai and Lilly cost position in payer budgets
Figure 40. Market-access negotiation structure diagram
Figure 41. High-cost therapy payer negotiation flow
Figure 42. Public-finance exposure map: central and municipal
Figure 43. Household-finance impact pathway
Figure 44. Informal-care data-gap map
Figure 45. Insurance-product design opportunity map
Figure 46. LTCI planning application framework
Figure 47. Risk-transfer opportunity map for reinsurers
Figure 48. Policy-event scenario agenda schematic
Figure 49. Methodology flow: synthesis, model structure, assumptions
Figure 50. Data cut-off and update cadence schematic

Dementia Care Costs: Formal and Informal Burden to 2030 | Policy & Market Intelligence | US, EU5, Japan & China

Description

Table of Contents

List of Tables

Table of Content

1. Executive Summary

2. Dementia Care Costs: Policy and Institutional Framework

3. Reimbursement, Pricing, and Funding Flows

4. Provider and Operator Landscape: Structure and Economics

5. Workforce and Capacity Analysis

6. Technology and Vendor Ecosystem

7. International Comparison: US, EU5, and China

8. Implications for Entrants and Investors

9. Appendix: Methodology and Sources

Companies Mentioned

List of Tables

List of Figures